Retatrutide (GLP-1/GIP/Glucagon) 10MG

Retatrutide (GLP-1/GIP/Glucagon) 10MG

$169.00

For Research Use Only — Not for Human or Veterinary Consumption. Sold by Longevra Research LLC for laboratory use only. Not approved by the FDA. Not intended to diagnose, treat, cure, prevent, or mitigate any disease.

Retatrutide is a triple-agonist peptide. It binds the GIP, GLP-1, and glucagon receptors. Eli Lilly developed it; the published cell-model work is from 2022 onward. Researchers studying incretin and glucagon signaling use it as a tool compound for triple-receptor pharmacology.

What ships: 10MG per vial · ≥99% HPLC-verified purity · MS-confirmed identity · batch-specific Certificate of Analysis.

Category:
Bulk pricing — auto-applied at checkout
QuantityYou savePer unit
3+5%$160.55
5+10%$152.10
10+15%$143.65

Description

Retatrutide is a synthetic triple agonist peptide engineered to activate the GLP-1 receptor, the GIP receptor, and the glucagon receptor. The molecule incorporates a fatty acid moiety enabling albumin binding for extended plasma half-life and has been a subject of preclinical metabolic research as a novel polypharmacological tool compound within the incretin and glucagon-family receptor literature.

Research Context

Preclinical investigations have examined retatrutide in rodent and in vitro models of metabolic signaling, energy expenditure, and adipose tissue biology. Laboratory studies have characterized the compound’s relative potency and signaling profile across its three receptor targets, with research interest in how simultaneous glucagon receptor engagement modifies the metabolic profile relative to dual GLP-1/GIP compounds. Researchers have used retatrutide as a reference triple-agonist in cell-culture assays measuring cAMP generation, receptor internalization, and downstream gene expression. This product is offered strictly as a research reagent for in vitro and preclinical metabolic biology workflows; no human or clinical application is suggested.

Reconstitution & Storage

  • Recommended reconstitution: 2-3 mL bacteriostatic water per 10 mg vial
  • Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
  • Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Parameter Specification
Purity ≥99% (HPLC)
Identity Confirmed by mass spectrometry
Form Lyophilized powder
Vial size 10 mg
COA Included with order

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide (GLP-1/GIP/Glucagon) 10MG”

Your email address will not be published. Required fields are marked *